Eos Energy stock falls after Fuzzy Panda issues short report
CARLSBAD - Alphatec Holdings (NASDAQ:ATEC) shares surged 21% after the spine-focused medical technology company reported better-than-expected third-quarter results and raised its full-year guidance.
The company posted adjusted earnings of $0.03 per share for the third quarter, significantly outperforming analyst expectations of a $0.04 per share loss. Total revenue jumped 30% YoY to $197 million, driven by a 31% increase in surgical revenue to $177 million and 29% growth in EOS revenue to $20 million.
Alphatec’s strong performance was reflected in its improved profitability metrics, with adjusted EBITDA reaching $26 million or 13% of revenue, representing an 840 basis point expansion compared to the same period last year. The company also generated $5 million in free cash flow during the quarter.
"I’m extremely proud of the entire ATEC team for delivering another quarter of industry-leading results," said Pat Miles, Chairman and Chief Executive Officer. "Our singular focus on spine is compelling an ever-growing number of surgeons to say yes to ATEC."
Following the strong quarter, Alphatec raised its full-year 2025 guidance, now expecting total revenue to grow 24% to $760 million, up from its previous forecast of $742 million. The company also increased its adjusted EBITDA guidance to approximately $91 million from $83 million previously.
The company reported 26% growth in net new surgeon users, which it considers a key leading indicator of future growth. Alphatec ended the quarter with $156 million in cash.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.